We are on a path to commercialize proton computed tomography (pCT), a new medical imaging modality that will take the treatment of cancer and cardiac arrhythmia to the next level. pCT makes a 3D image of the human body using a proton beam rather than X-rays. This is important because it solves a critical problem in proton beam therapy (PBT). PBT has been growing exponentially worldwide for ~15 years as a preferred treatment for cancer. And now clinical trials are underway to utilize PBT as a first-line treatment for cardiac arrhythmias (VT and A-fib) after success with animals. Cancer patients and their doctors often face agonizing trade-offs in the fight against cancer but hope is here. Cutting edge technology from Proton Calibration Technologies (PCT) puts more options at the fingertips of radiation oncologists to help improve patient outcomes while reducing treatment costs. PCT is on a mission to take the fight against cancer to the next level with our precise, proven, and proprietary technology. pCT is not only transformative enabling technology for PBT treatment of cancer. It will revolutionize how cardiac ablation is performed using proton beams. No longer will patients have to endure hours under anesthesia and internal bleeding. With pCT, durable ablation of cardiac arrhythmia can be performed without anesthesia and in less than half an hour. Our key insight is that pCT requires a different imaging algorithm. PCTs novel, patent-pending proprietary algorithm provides a direct measurement of proton stopping powers for 1 millimeter voxels within the 3D region of interest with an accuracy of 1% of the true value. PCT is currently vetting strategic technology partnership opportunities to help make this cutting edge medical imaging modality available to proton beam therapy centers around the world.